M&A Deal Summary |
|
|---|---|
| Date | 2022-10-11 |
| Target | StoCastic |
| Sector | Information Technology |
| Buyer(s) | Beckman Coulter |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1935 |
| Sector | Life Science |
| Employees | 11,900 |
Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. More than 275,000 Beckman Coulter systems operate in both Diagnostics and Life Sciences laboratories on seven continents. For more than 75 years, our products have been making a difference in peoples' lives by improving the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector: Information Technology M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 4 of 4 |
| State: Maryland M&A | 1 of 1 |
| Country: United States M&A | 5 of 5 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-16 |
Siemens Healthcare Diagnostics - Clinical Microbiology Business
United States Siemens Healthcare Diagnostics - Clinical Microbiology Business is an established in microbial identification and antibiotic sensitivity testing (ID/AST). |
Buy | - |
